Microsoft CEO & CFO and GW Pharmaceuticals CEO

Mad Money w/ Jim Cramer

CNBC

Investing, Business, News

4.3 • 4K Ratings

🗓️ 17 January 2020

⏱️ 45 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

After hitting an all time high today, Cramer’s heading out west to Redmond, Washington, where he’s sitting down with Microsoft’s CEO and CFO after the company announced its plan to be better than carbon neutral by 2030. And, last night before leaving San Francisco, Cramer spoke with GW Pharmaceuticals CEO to learn more about the company’s 4Q ‘19 pre-announcement and the success of its cannabis-based drug, Epidiolex.

Transcript

Click on a timestamp to play from that location

0:00.0	My mission is simple to make you money.
0:05.0	I'm here to level the playing field for all investors.
0:08.0	There's always a more market summer,
0:10.0	and I promised to help you find it.
0:12.0	The man money starts now!
0:14.0	Hey, I'm Kramer.
0:19.0	Welcome to Mayor Buddy.
0:20.0	Welcome to the West Coast edition of Kramer Raka.
0:23.0	I've been one of my friends who's trying to make me somebody.
0:25.0	My job, not just to entertain, but to educate teachers,
0:27.0	putting in contact.
0:28.0	So call me at 1-800-723-CBC, or tweet me, act Jim Kramer.
0:33.0	This week, it's like the whole world's been turned upside down.
0:37.0	We got record highs, downstirging 267 points.
0:40.0	Uh, as you think you're getting 0.84% NASDAQ voting 1.06%.
0:47.0	Texas is in terrific earnings forecast, and yesterday's trade deal with China.
0:51.0	But at the same time, individual companies are taking action to fight climate change
0:55.0	in a way that's unprecedented.
0:56.0	These are the issues that could hurt earnings per share.
1:00.0	Yet the market doesn't seem to care.
1:02.0	Market seems to like it.
1:03.0	It's insane!
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.